tirzepatide cancer Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes and weight loss (Mounjaro, Zepbound)—can also shrink breast tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Weight-loss drugs may lower cancer

The results showed that LY3298176 had a dose-dependent effect on reducing HbA1c levels, and the reduction was greater than that achieved with dulaglutide or the placebo

Counterintuitively, increasing calories slightly, particularly from protein, sometimes breaks plateaus by restoring metabolic rate

Shima Hadidchi, MD Under the medical supervision of Board-certified and experienced primary care physician, Dr

When a medication is on this list, compounding pharmacies can compound the drug to help increase the supply

While researchers are still gathering data about the weight loss benefits of both drugs, Tirzepatide is likely a more effective weight loss injection for some people

Vive Ageless